Reviewed,
UniProtKB/Swiss-Prot P08905 (LYZ2_MOUSE)
Last modified
June 16, 2009.
Version 99.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Lysozyme C-2 EC=3.2.1.17 Alternative name(s): Lysozyme C type M 1,4-beta-N-acetylmuramidase C | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 148 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents. Lyz2 is active against a range of Gram-positive and Gram-negative bacteria. More effective than Lyz1 in killing Gram-negative bacteria. Lyz1 and Lyz2 are equally effective in killing Gram-positive bacteria. Ref.7 |
| Catalytic activity | Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins. |
| Subunit structure | Monomer. Ref.10 |
| Tissue specificity | Expressed weakly in myeloblasts, moderately in immature macrophages, and strongly in both mature macrophages and macrophage-rich tissues. |
| Disruption phenotype | Mice display increased inflammation in response to M.luteus infection, impaired digestion of M.luteus cell walls, decreased clearance of P.aeruginosa from infected airways, increased susceptibility to K.pneumoniae infection and increased bacterial burden and mortality following infection with various Gram-negative bacteria. Lyz2 is non-immunogenic in wild-type mice but is rendered immunogenic in mutants. Ref.7 Ref.5 Ref.6 Ref.8 Ref.9 |
| Miscellaneous | Lysozyme C is capable of both hydrolysis and transglycosylation; it shows also a slight esterase activity. It acts rapidly on both peptide-substituted and unsubstituted peptidoglycan, and slowly on chitin oligosaccharides. |
| Sequence similarities | Belongs to the glycosyl hydrolase 22 family. |
| Biophysicochemical properties | pH dependence: Optimum pH is 5. |
Ontologies
| Keywords | |
|---|---|
| Domain | Signal |
| Molecular function | Antimicrobial Bacteriolytic enzyme Glycosidase Hydrolase Milk protein |
| PTM | Disulfide bond |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | cell wall macromolecule catabolic process Inferred from electronic annotation. Source: InterPro cytolysisInferred from electronic annotation. Source: UniProtKB-KW defense response to Gram-negative bacterium Ref.7Inferred from direct assay. Source: UniProtKB defense response to Gram-positive bacterium Ref.7Inferred from direct assay. Source: UniProtKB |
| Molecular function | lysozyme activity Ref.5 Inferred from direct assay. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 18 | 18 | Ref.4 | |||||||||||||||||||||||||||||||||||||
| Chain | 19 – 148 | 130 | Lysozyme C-2 | PRO_0000018472 | ||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||
| Active site | 53 | 1 | By similarity | |||||||||||||||||||||||||||||||||||||
| Active site | 71 | 1 | By similarity | |||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 24 ↔ 146 | Ref.10 | ||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 48 ↔ 134 | Ref.10 | ||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 83 ↔ 99 | Ref.10 | ||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 95 ↔ 113 | Ref.10 | ||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||
| Helix | 23 – 33 | 11 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 39 – 41 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 43 – 53 | 11 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 58 | 3 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 61 – 64 | 4 | ||||||||||||||||||||||||||||||||||||||
| Helix | 65 – 67 | 3 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 69 – 72 | 4 | ||||||||||||||||||||||||||||||||||||||
| Turn | 73 – 76 | 4 | ||||||||||||||||||||||||||||||||||||||
| Turn | 79 – 81 | 3 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 82 – 84 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 99 – 102 | 4 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 103 – 105 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 108 – 118 | 11 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 120 – 122 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 124 – 126 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 128 – 131 | 4 | ||||||||||||||||||||||||||||||||||||||
| Turn | 132 – 136 | 5 | ||||||||||||||||||||||||||||||||||||||
| Helix | 140 – 143 | 4 | ||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Mouse lysozyme M gene: isolation, characterization, and expression studies." Cross M., Mangelsdorf I., Wedel A., Renkawitz R. Proc. Natl. Acad. Sci. U.S.A. 85:6232-6236(1988) [PubMed: 3413093] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed: 16141072] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: C57BL/6J. Tissue: Bone marrow macrophage and Pancreatic islet. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: FVB/N and FVB/N-3. Tissue: Mammary tumor. |
| [4] | "Sequence studies of mouse lysozyme." Riblet R.J. (In) Osserman E.F., Canfield R.E., Beychok S. (eds.); Lysozyme, pp.89-93, Academic Press, New York (1974) Cited for: PROTEIN SEQUENCE OF 19-78. |
| [5] | "Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan." Ganz T., Gabayan V., Liao H.-I., Liu L., Oren A., Graf T., Cole A.M. Blood 101:2388-2392(2003) [PubMed: 12411294] [Abstract] Cited for: DISRUPTION PHENOTYPE. |
| [6] | "Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection." Markart P., Korfhagen T.R., Weaver T.E., Akinbi H.T. Am. J. Respir. Crit. Care Med. 169:454-458(2004) [PubMed: 14617511] [Abstract] Cited for: DISRUPTION PHENOTYPE. |
| [7] | "Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P." Markart P., Faust N., Graf T., Na C.-L., Weaver T.E., Akinbi H.T. Biochem. J. 380:385-392(2004) [PubMed: 14977423] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [8] | "Mouse lysozyme-M knockout mice reveal how the self-determinant hierarchy shapes the T cell repertoire against this circulating self antigen in wild-type mice." Sinha P., Chi H.H., Kim H.R., Clausen B.E., Pederson B., Sercarz E.E., Forster I., Moudgil K.D. J. Immunol. 173:1763-1771(2004) [PubMed: 15265906] [Abstract] Cited for: DISRUPTION PHENOTYPE. |
| [9] | "Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M." Cole A.M., Thapa D.R., Gabayan V., Liao H.-I., Liu L., Ganz T. J. Leukoc. Biol. 78:1081-1085(2005) [PubMed: 16204648] [Abstract] Cited for: DISRUPTION PHENOTYPE. |
| [10] | "Solution structure and activity of mouse lysozyme M." Obita T., Ueda T., Imoto T. Cell. Mol. Life Sci. 60:176-184(2003) [PubMed: 12613666] [Abstract] Cited for: STRUCTURE BY NMR OF 19-148, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, DISULFIDE BONDS. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M21050 M21049 Genomic DNA. Translation: AAA39473.1. AK148516 mRNA. Translation: BAE28595.1. AK150998 mRNA. Translation: BAE30022.1. Different initiation. AK153244 mRNA. Translation: BAE31835.1. Different initiation. AK153475 mRNA. Translation: BAE32025.1. AK159276 mRNA. Translation: BAE34954.1. Different initiation. AK159640 mRNA. Translation: BAE35253.1. BC002069 mRNA. Translation: AAH02069.1. BC019611 mRNA. Translation: AAH19611.1. BC054463 mRNA. Translation: AAH54463.1. | |||||||||||||
| IPI | IPI00107952. | ||||||||||||
| PIR | A31239. | ||||||||||||
| RefSeq | NP_059068.1. | ||||||||||||
| UniGene | Mm.45436 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein family/group databases | |||||||||||||
| CAZy | GH22. Glycoside Hydrolase Family 22. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUSG00000069516. Mus musculus. [Contig view] | ||||||||||||
| GeneID | 17105. | ||||||||||||
| KEGG | mmu:17105. | ||||||||||||
Organism-specific databases | |||||||||||||
| MGI | MGI:96897. Lyz2. | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P08905. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 3.2.1.17. 244. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P08905. | ||||||||||||
| Bgee | P08905. | ||||||||||||
| CleanEx | MM_LYZ2. | ||||||||||||
| GermOnline | ENSMUSG00000069516. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001916. Glyco_hydro_22. IPR019799. Glyco_hydro_22_CS. IPR000974. Glyco_hydro_22_lys. [Graphical view] | ||||||||||||
| Pfam | PF00062. Lys. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00137. LYSOZYME. PR00135. LYZLACT. | ||||||||||||
| SMART | SM00263. LYZ1. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00128. LACTALBUMIN_LYSOZYME_1. 1 hit. PS51348. LACTALBUMIN_LYSOZYME_2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 291248. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | LYZ2_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P08905 Secondary accession number(s): Q3TXG2 Q8VE78 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Glycosyl hydrolases Classification of glycosyl hydrolase families and list of entries |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


